Australia Markets open in 44 mins

Healius Limited (HLS.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
3.0300+0.0100 (+0.33%)
At close: 04:10PM AEDT
Full screen
Previous close3.0200
Bid3.0100 x 0
Ask2.8800 x 0
Day's range2.9950 - 3.0300
52-week range2.5600 - 4.6400
Avg. volume2,816,790
Market cap1.76B
Beta (5Y monthly)0.89
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yield0.12 (4.41%)
Ex-dividend date07 Sept 2022
1y target estN/A
  • Business Wire

    RingCentral Selected by Healius to Transform Telephony and Contact Center Platform Australia-wide

    SYDNEY, Australia & BELMONT, Calif., November 02, 2022--Healius Limited (Healius) (ASX: HLS), one of Australia’s leading healthcare companies, has selected RingCentral, Inc. (NYSE: RNG) to deploy an integrated unified communications as a service (UCaaS) and contact center as a service (CCaaS) solution. This technology investment is designed to improve the doctor and patient experience in Healius’ pathology and diagnostic imaging practices through improvements in communications, initially within

  • Business Wire

    C2N Diagnostics and Healius Ltd Announce Partnership to Bring PrecivityAD™ and Related Brain Health Biomarkers to Patients in Australia

    ST. LOUIS, August 30, 2022--C2N Diagnostics, a leader in advanced brain health diagnostics, and Healius Ltd (ASX:HLS), one of Australia's leading listed healthcare companies, today announced a partnership that will aim to bring C2N’s PrecivityAD™ blood test and related brain health biomarkers to the forefront of memory and dementia care in Australia. The partnership represents C2N’s first international country-wide agreement as it expands its offerings beyond the United States and Europe.